Laurie Adami's experience with CAR T-cell therapy highlights its potential in treating Non-Hodgkin Lymphoma, emphasizing the ...

Tea planter Vishal Mahindra was twice diagnosed with non-Hodgkin's lymphoma, a type of blood cancer that develops in the ...

Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...

A breakthrough CAR-T cell therapy, Qartemi, has been approved for blood cancer patients in India, offering new hope to those ...

The FDA has granted Fast Track Designation to Adicet Bio’s ADI-001, an allogeneic gamma delta CAR T-cell therapy, for ...

A total of 20% of patients with a diagnosis of Hodgkin lymphoma (HL ... is the most powerful factor to decide relapse treatment. The second important factor is the response to salvage chemotherapy ...

Steve Bove, who has long been associated as a coach and former president and supporter of Montesano Little League, was recently diagnosed with Stage 3 non-Hodgkin’s Lymphoma and is currently ...

The CHMP recommends approval of Bristol Myers' Opdivo plus Yervoy for the first-line treatment of hepatocellular carcinoma ...

Trusted resource of information on Cancer that includes articles, news, videos, animations, quizzes, calculators and drugs.

A study from the University of Birmingham, UK, has indicated that the use of digoxin could lead to substantial cost savings ...

Oct. 17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin ... Lymphoma June 19, 2024 — Researchers have developed a non-chemotherapy treatment ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...